临床肝胆病杂志2017，Vol.33Issue(5)：825-828,4.DOI:10.3969/j.issn.1001-5256.2017.05.006
中医药抗肝纤维化疗效评价的探索
An exploration of therapeutic evaluation of traditional Chinese medicine in treatment of hepatic fibrosis
徐列明1
作者信息
- 1. 上海中医药大学附属曙光医院,上海中医药大学肝病研究所,上海201203
- 折叠
摘要
Abstract
China has become one of the leading counties in the world to treat hepatic fibrosis with Chinese patent drugs.The therapeutic effect of traditional Chinese medicine (TCM) should be evalvated from the aspects of short-term therapeutic effect,long-term therapeutic effect,and effect of relief of symptoms.This article introduces the results of our exploration of the application of liver stiffness measurement to evaluate therapeutic effect,five-year survival rate to assess]ong-term therapeutic effect,and a "TCM syndrome scale" to evaluate effect of relief of symptoms,suggesting that the Chinese patent drug Fuzheng Huayu capsules/tablets have a marked clinical effect in the treatment of hepatic fibrosis.It is recommended to use serological diagnostic models,conduct prospective studies with long-term follow-up,and analyze the samples and data accumulated over a long period of time,in order to perfect the methods for evaluating the outcome of hepatic fibrosis.关键词
肝硬化/中成药/治疗结果Key words
liver cirrhosis/Chinese patent drugs/treatment outcome分类
医药卫生引用本文复制引用
徐列明..中医药抗肝纤维化疗效评价的探索[J].临床肝胆病杂志,2017,33(5):825-828,4.
